Clinical Trials Browser

Phase NA × Rituximab × Other hematologic neoplasm × Clear all

NCT00648037 2016-02-01

Rituximab (Rituxan) for the Prevention of EBV-LPD Epstein Barr Virus (EBV) Lymphoproliferative Disorder Post T Cell Depleted Unrelated and HLA Mis-matched Related HSCT

Phase NA Completed

26 enrolled 6 charts

LymphoidMyeloidOther hematologic neoplasm

Hodgkin Disease, Leukemia, Lymphoma, Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes

NCT01230788 2014-12-01

Rituximab

Phase NA Terminated

1 enrolled 3 charts

LymphoidOther hematologic neoplasm

Leukemia, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00476229 2012-08-07

Thymoglobulin and Total Lymphoid Irradiation for Hematologic Malignancies

Phase NA Completed

20 enrolled 5 charts

LymphoidOther hematologic neoplasm

Hodgkin Disease, Leukemia, Lymphoma, Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell

NCT00038844 2011-11-02

Safety and Efficacy of Campath in Nonmyeloablative Transplantation

Phase NA Completed

LymphoidOther hematologic neoplasm

Leukemia, Lymphoma

NCT00274794 2011-03-29

VP and G-CSF With or Without Rituximab in Autologous Peripheral Stem Cell Transplant For NHL

Phase NA Completed

LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma